Research Output per year
Fingerprint Dive into the research topics where Hun Ju Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Mantle-Cell Lymphoma
Medicine & Life Sciences
Radiotherapy
Medicine & Life Sciences
Hodgkin Disease
Medicine & Life Sciences
Lymphoma
Medicine & Life Sciences
Acute Myeloid Leukemia
Medicine & Life Sciences
Survival
Medicine & Life Sciences
B-Cell Lymphoma
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2006 2019
ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: A randomized phase 2 study
Strati, P., Fanale, M. A., Oki, Y., Turturro, F., Fayad, L. E., Bartlett, N. L., Gladstone, D. E., Kasamon, Y. L., Portlock, C. S., Wilson, W. H., Goy, A., Younes, A. & Lee, H. J., Jan 31 2019, In : Haematologica. 104, 2, p. e65-e67Research output: Contribution to journal › Letter
Hodgkin Disease
Rituximab
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
Milgrom, S. A., Elhalawani, H., Lee, J., Wang, Q., Mohamed, A. S. R., Dabaja, B. S., Pinnix, C. C., Gunther, J., Court, L. E., Uppore Kukkillaya, A. R., Fuller, C., Akhtari, M., Aristophanous, M., Mawlawi, O., Chuang, H. H., Sulman, E. P., Lee, H. J., Hagemeister, F. B., Oki, Y., Fanale, M. A. & 1 others, , Dec 1 2019, In : Scientific reports. 9, 1, 1322.Research output: Contribution to journal › Article
Open Access
Hodgkin Disease
Glycolysis
Tumor Burden
Mediastinal Diseases
Area Under Curve
A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma
Lee, H. J., Badillo, M., Romaguera, J. & Wang, L., Feb 1 2019, In : British Journal of Haematology. 184, 3, p. 460-462 3 p.Research output: Contribution to journal › Letter
Mantle-Cell Lymphoma
carfilzomib
Erratum to: Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma: Low-dose radiotherapy for adnexal b-cell lymphoma (Head & Neck, (2017), 39, 6, (1095-1100), 10.1002/hed.24717)
Pinnix, C. C., Dabaja, B. S., Milgrom, S. A., Smith, G. L., Abou Yehia, Z., Nastoupil, L., Romaguera, J., Turturro, F., Fowler, N., Fayad, L. E., Westin, J. R., Neelapu, S. S., Fanale, M. A., Rodriguez, M. A., Hagemeister, F. B., Lee, H. J., Oki, Y., Wang, L., Samaniego, F., Chi, T. L. & 1 others, , May 1 2019, In : Head and Neck. 41, 5, 1 p.Research output: Contribution to journal › Comment/debate
Open Access
B-Cell Lymphoma
Names
Lymphoma
Neck
Radiotherapy
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma
Pinnix, C. C., Milgrom, S. A., Cheah, C. Y., Gunther, J., Ludmir, E. B., Wogan, C. F., Nastoupil, L., Neelapu, S. S., Westin, J. R., Lee, H. J., Iyer, S. P., Steiner, R. E., Fayad, L. E., Fowler, N., Wang, L., Samaniego, F., Rodriguez, M. A., Rich, A. E., Medeiros, L. J. & Dabaja, B. S., Jan 1 2019, In : Blood Advances. 3, 9, p. 1356-1367 12 p.Research output: Contribution to journal › Article
Open Access
Hodgkin Disease
Radiotherapy
Disease-Free Survival
Survival Rate
Therapeutics